Search
for
Sort by
Research 61–90 of 1000+
- Latest advances in oral hormonal male contraception: efficacy, mechanisms of action, and future perspectives
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Industry updates from the field of stem cell research and regenerative medicine in June 2019
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- 5% Minoxidil topical foam for men: Hair growth in millennials – a post hoc analysis
- 5% Minoxidil topical foam on women: Menopause and other covariates
- Alopecia in patients treated with molecularly targeted anticancer therapies
- PC-SPES Studies Promising, But Manufacturer Shuts Down
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Dutasteride
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Ruxolitinib: A novel molecule in the management of dermatological disorders
- Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
- Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
- Tebentafusp-tebn (Kimmtra®)
- Incidence of alopecia from endocrine therapies in cancer
- Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
- c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer
- Male hormonal contraception: looking back and moving forward
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Getting to grips with hair loss
- Men??s Health
- Macrophages in Skin Wounds: Functions and Therapeutic Potential
- Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
- Anthracycline analogs The past, present, and future
- Androgens and alopecia
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Interventions for preventing the progression of autosomal dominant polycystic kidney disease